Wastewater Study Tracks Illicit Drug Use Across England - Scorecard - MDSpire

Wastewater Study Tracks Illicit Drug Use Across England

A year-long LC-MS/MS study suggests wastewater surveillance can reveal shifts in drug consumption linked to public events, weekends, and law enforcement activity

  • May 27, 2026

  • 3 min

Share

Clinical Scorecard: Wastewater Study Tracks Illicit Drug Use Across England

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationUrban populations across England, covering approximately 21% of the population.
Care Setting

Key Highlights

  • Study analyzed 1,746 wastewater samples from 15 treatment plants.
  • Cocaine showed the highest average population-normalized daily load.
  • Clear weekend increases in cocaine and MDMA markers observed.
  • Cocaine consumption markers fell significantly following a major drug seizure.
  • Comparison with European sites showed higher cocaine and ketamine loads in England.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Utilize high-frequency chemical monitoring for tracking drug consumption changes.

      Risks

        Patient & Prescribing Data

        Not applicable as this study focuses on wastewater analysis.

        Clinical Best Practices

        • Implement rapid direct-injection workflows for efficient sample analysis.
        • Ensure quality controls and blanks are part of the monitoring process.
        • Consider temporal and spatial coverage when designing monitoring programs.

        Related Resources & Content

        Original Source(s)

        Wastewater Study Tracks Illicit Drug Use Across England

        • May 27, 2026

        Related Content

        GRAPPA, EULAR Criteria May Identify Complex PsA

        Application of newly proposed GRAPPA and EULAR criteria in a longitudinal cohort identified progressively smaller groups of patients with early psoriatic arthritis who experienced persistently worse patient-reported outcomes.

        Skin Deep Survival

        Peptidomics via LC-MS/MS links early skin immune maturation to recovery from chytrid fungus in common midwife toads  

        • July 23, 2026

        • 3 min
        Bringing it Home: Why We Switched to In-House WGS

        Annette Kim shares her experience of a real-world clinical laboratory transition to whole-genome sequencing

        • July 24, 2026

        • 8 min